Target intelligence / Profile preview

Serum protein corona on DiR-labeled nanoparticle surface (PC)

Target
PC
Molecular classification
Protein complex, Biomolecular interface
01

Overview

The serum protein corona on DiR-labeled nanoparticle (DIR-NP) surfaces is a dynamic layer of adsorbed proteins that forms when these nanoparticles encounter biological fluids like blood or serum (Monopoli et al., 2012, Nature Nanotechnology). This corona essentially replaces the synthetic surface of the nanoparticle with a biological interface, which determines the nanoparticle's biological identity and governs its interactions with the mononuclear phagocyte system, cellular receptors, and the immune system (Walkey & Chan, 2012, Chemical Society Reviews). While the corona can facilitate cellular uptake through specific protein-receptor interactions, it often leads to the rapid clearance of nanoparticles from circulation or can mask targeting ligands, thereby reducing therapeutic efficacy (Nel et al., 2009, Nature Materials). In the context of DIR-NPs, which are frequently used for in vivo imaging and tracking, the protein corona significantly influences the fluorescence signal's distribution and the nanoparticle's eventual fate in the body (Cedervall et al., 2007, PNAS). Understanding the composition of this corona is critical for the successful translation of nanomedicines, as it significantly influences the safety and efficacy of the delivery system.

Other names
Nanoparticle-protein coronaBiomolecular coronaHard coronaSoft coronaProtein adsorption layerDiR-NP protein corona
02

Mechanism of action

Not applicable as the protein corona is a biological phenomenon affecting drug delivery systems rather than a target for therapeutic drugs.

03

Biological functions

OpsonizationCellular uptakeBiodistributionImmune recognitionPhagocytosis
04

Disease associations

CancerInflammationImmune-mediated disorders
05

Safety considerations

Accelerated blood clearance (ABC) effectImmunogenicityOff-target accumulationToxicityLoss of targeting specificity

Beyond the preview

Go deeper on Serum protein corona on DiR-labeled nanoparticle surface (PC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serum protein corona on DiR-labeled nanoparticle surface (PC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call